These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3339977)

  • 1. [Efficacy of the conservative treatment of patients with inoperable esophageal cancer].
    Azhigaliev NA; Sadykov SS; Kusherbaev SK
    Med Radiol (Mosk); 1988 Jan; 33(1):40-4. PubMed ID: 3339977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of radiation and chemoradiation therapy in esophageal cancer].
    Azhigaliev NA; Kusherbaev SK; Sadykov SS; Asanov AA; Fel'dman SZ
    Med Radiol (Mosk); 1990 Jun; 35(6):20-3. PubMed ID: 1694002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy of esophageal cancer using local hyperthermia and metronidazole (polyradiomodification)].
    Isaev IG; Beĭbutov ShM
    Med Radiol (Mosk); 1986 Nov; 31(11):30-4. PubMed ID: 3784823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
    Zhang Z; Liao Z; Jin J; Ajani J; Chang JY; Jeter M; Guerrero T; Stevens CW; Swisher S; Ho L; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):656-64. PubMed ID: 15708243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of radiotherapy in the management of esophageal cancer].
    Serkies K; Badzio A; Jassem J
    Pol Merkur Lekarski; 2005 Mar; 18(105):332-5. PubMed ID: 15997646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant therapy of esophageal cancer.
    Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
    Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
    Brenner B; Ilson DH; Minsky BD; Bains MS; Tong W; Gonen M; Kelsen DP
    J Clin Oncol; 2004 Jan; 22(1):45-52. PubMed ID: 14701767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer.
    Kim C; Monjazeb AM; Suntharalingam M; Giesinger KR; Blackstock AW
    Clin Adv Hematol Oncol; 2009 May; 7(5):327-333, 342. PubMed ID: 19521322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psoriatic arthritis: combined treatment with prospidin and methotrexate].
    Simonova OV; Nemtsov BF
    Ter Arkh; 2005; 77(8):60-4. PubMed ID: 16206608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.
    Kunisaki C; Imada T; Yamada R; Hatori S; Kinbara K; Watai K; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
    Hepatogastroenterology; 2006; 53(69):366-71. PubMed ID: 16795974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.
    Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of radiotherapy and chemoradiotherapy of disseminated laryngeal cancer].
    Borisevich NV; Baĭmakanova SSh
    Med Radiol (Mosk); 1984 Sep; 29(9):30-5. PubMed ID: 6482703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature].
    Fritz P; Stoll P; Wannenmacher M; Zierhut D
    Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemoradiotherapy for neural invasion in an advanced esophageal cancer.
    Tanaka A; Ishikawa S; Okuno K; Shiozaki H
    Hepatogastroenterology; 2008; 55(84):963-6. PubMed ID: 18705308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications.
    Morita M; Masuda T; Okada S; Yoshinaga K; Saeki H; Tokunaga E; Endo K; Emi Y; Kakeji Y; Maehara Y
    Anticancer Res; 2009 Jul; 29(7):2555-62. PubMed ID: 19596928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
    Tedesco KL; Berlin J; Blanke CD; Teng M; Choy H; Roberts J; Beauchamp RD; Leach S; Wyman K; Tarpley J; Shyr Y; Caillouette C; Chakravarthy B
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1364-70. PubMed ID: 15817338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
    Ohtsu A
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):232-40. PubMed ID: 9474933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.